This announcement is a separate document:
Esperion Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
19:56
The Federal Reserve's interest rate cut of 25 basis points seems almost certain, but is it wise?
USD/CNY+0.02%
19:54
Jiangxi: From January to November, fixed Assets investment increased by 4.7% year-on-year.
19:53
Pfizer's stock rose over 3% in Pre-Market Trading, with the company expecting revenues of 61 billion to 64 billion dollars in 2025, and an adjusted EPS of 2.80 to 3.00 dollars in 2025.
PFE-1.29%